Multifocal ERG and Microperimetry Changes in Response to Ranibizumab Treatment of Neovascular AMD: Randomized Phase 2 Open-Label Study
Masumi G Asahi, Josh Wallsh, Spencer M Onishi, Shari Kuroyama, Ron P Gallemore Clinical Research Department, Retina Macula Institute, Torrance, CA, USACorrespondence: Ron P Gallemore Tel +1 (310) 944-9393Fax +1 (310) 944-3393Email rongallemoremd@gmail.comPurpose: To compare monthly versus pro re nat...
Main Authors: | Asahi MG, Wallsh J, Onishi SM, Kuroyama S, Gallemore RP |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2020-10-01
|
Series: | Clinical Ophthalmology |
Subjects: | |
Online Access: | https://www.dovepress.com/multifocal-erg-and-microperimetry-changes-in-response-to-ranibizumab-t-peer-reviewed-article-OPTH |
Similar Items
-
Testing the clinical value of multifocal electroretinography and microperimetry and the effects of intravitreal therapy with ranibizumab on macular function in the course of wet age-related macular degeneration: a 1-year prospective study
by: Reinsberg M, et al.
Published: (2017-04-01) -
Correspondence between Multifocal Electroretinography and Microperimetry in Benign Concentric Annular Macular Dystroph
by: Serra Arf, et al.
Published: (2011-10-01) -
Efficiency analysis by mfERG and OCT of intravitreal injection with ranibizumab on diabetic macular edema
by: Hong-Xia Bian, et al.
Published: (2020-07-01) -
Microperimetry
by: Hakan Özdemir,, et al.
Published: (2011-12-01) -
Combination verteporfin photodynamic therapy ranibizumab-dexamethasone in choroidal neovascularization due to age-related macular degeneration: results of a phase II randomized trial
by: Gallemore RP, et al.
Published: (2017-01-01)